| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 07, 2012 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,650 | -- | 6,650 | |
| Aug 07, 2012 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,850 | -- | 17,350 | |
| Aug 07, 2012 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,650 | -- | 6,650 | |
| Aug 03, 2012 | EVP - CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,358 | $10.70 | 37,175 | |
| Aug 03, 2012 | EVP - CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 814 | $10.70 | 36,361 | |
| Aug 03, 2012 | SVP, GM - International | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 367 | $10.70 | 7,616 | |
| Aug 03, 2012 | SVP, GM - International | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 630 | $10.70 | 6,986 | |
| Aug 03, 2012 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 357 | $10.70 | 20,565 | |
| Aug 03, 2012 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 759 | $10.70 | 19,806 | |
| Jul 17, 2012 | Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,000 | $11.67 | 38,000 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.